European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Rise for Week

MT Newswires Live
Yesterday

European equities traded in the US as American depositary receipts were tracking lower late Friday morning, falling 0.85% to 1,882.19 on the S&P Europe Select ADR Index, which is up 0.9% for the week so far.

From continental Europe, the gainers were led by internet ad firm Criteo (CRTO) and consumer goods company Unilever (UL), which rose 2.1% and 2% respectively. They were followed by biopharmaceutical companies argenx (ARGX) and Cellectis (CLLS), which were up 1.8% and 0.7% respectively.

The decliners from continental Europe were led by telecommunications company Nokia (NOK) and semiconductor company Sequans Communications (SQNS), which dropped 8.3% and 7.2% respectively. They were followed by biopharmaceutical company DBV Technologies (DBVT) and telecommunications company Ericsson (ERIC), which lost 5.4% and 2.9% respectively.

The gainers from the UK were led by biotech firm Trinity Biotech (TRIB) and alcoholic beverage company Diageo (DEO), which advanced 4.5% and 2.4% respectively. They were followed by tobacco company British American Tobacco (BTI) and educational publisher Pearson (PSO), which increased 2.1% and 1.9% respectively.

The decliners from the UK and Ireland were led by biotech firm Autolus Therapeutics (AUTL) and mining company BHP Group (BHP), which lost 6.3% and 5.3% respectively. They were followed by pharmaceutical company Silence Therapeutics (SLN) and biopharmaceutical company Akari Therapeutics (AKTX), which dropped 3% and 2.2% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10